Schrödinger is a global scientific company that specializes in computational chemistry and molecular modelling. They are known for developing highly sophisticated, physics-based modelling platforms that allow researchers to simulate and predict the behaviour of molecules with remarkable accuracy. These tools are widely used in the pharmaceutical and biotechnology industries to accelerate drug discovery by helping scientists identify promising drug candidates, and optimize molecular structures before moving to costly laboratory experiments. In addition to drug discovery Schrödinger’s technology is also applied in material science for designing new materials with specific properties, such as improved durability, efficiency, or performance. The company combines its software business with its own internal research programs, where it actively develops novel therapeutic candidates targeting diseases like cancer and other serious conditions. Through collaborations with academic institutions, research organizations, and major pharmaceutical companies, it plays a significant role in advancing modern scientific innovation and transforming how new drugs and materials are discovered and developed.